Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis

•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of steroid biochemistry and molecular biology 2015-06, Vol.150, p.86-96
Hauptverfasser: Hengevoss, Jonas, Piechotta, Marion, Müller, Dennis, Hanft, Fabian, Parr, Maria Kristina, Schänzer, Wilhelm, Diel, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 96
container_issue
container_start_page 86
container_title The Journal of steroid biochemistry and molecular biology
container_volume 150
creator Hengevoss, Jonas
Piechotta, Marion
Müller, Dennis
Hanft, Fabian
Parr, Maria Kristina
Schänzer, Wilhelm
Diel, Patrick
description •Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats. Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.
doi_str_mv 10.1016/j.jsbmb.2015.03.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680194874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960076015000886</els_id><sourcerecordid>1680194874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</originalsourceid><addsrcrecordid>eNp9kL2O1DAQgC0E4vYWngAJuaRJGNsb2yko0OrgkE6igdpy7MmtV0kcYu-J7XgH3pAnwWEPSqoZab75-wh5xaBmwOTbY31M3djVHFhTg6gBxBOyYVq1FeMcnpINtBIqUBKuyHVKRyiEYOo5ueKNapVQzYakfRy7MKGn2PfocqKxp3byS7zHqSS2i0NwNGVcYvBpLdH5cE7B2YFal8NDyGcaJ5oPSA_nOeaDHewY3K8fP-eQTyHb5Vzy-zhZv7Z8D-kFedbbIeHLx7glXz_cfNnfVnefP37av7-rnGjaXDEhZQ9McVReQSd436HT0qudtLLVmjsELVrtm6Ytp7fAleBNBxYabr22YkveXObOS_x2wpTNGJLDYbATxlMyTGpg7U6rXUHFBXVLTGnB3sxLGMvphoFZbZuj-WPbrLYNCLO63JLXjwtO3Yj-X89fvQV4dwGwvPkQcDHJBZwc-rAU2cbH8N8FvwG_9JVP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680194874</pqid></control><display><type>article</type><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</creator><creatorcontrib>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</creatorcontrib><description>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats. Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/j.jsbmb.2015.03.003</identifier><identifier>PMID: 25797375</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amides - pharmacology ; Anabolic Agents - pharmacology ; Anabolic steroids ; Androstenedione - pharmacology ; Aniline Compounds - pharmacology ; Animals ; Estradiol - blood ; Estrenes - pharmacology ; Follicle Stimulating Hormone - blood ; Gonadotropin-Releasing Hormone - blood ; Humans ; Hydrocortisone - blood ; Hypothalamic–pituitary–gonadal axis ; Hypothalamo-Hypophyseal System - drug effects ; Hypothalamo-Hypophyseal System - metabolism ; Inhibins - blood ; Injections, Subcutaneous ; Insulin-Like Growth Factor I - metabolism ; Luteinizing Hormone - blood ; Male ; Methandrostenolone - pharmacology ; Motor Activity ; Muscle Fibers, Skeletal - drug effects ; Muscle Fibers, Skeletal - metabolism ; Pituitary-Adrenal System - drug effects ; Pituitary-Adrenal System - metabolism ; Prolactin - blood ; Rats ; Rats, Wistar ; SARMs ; Testis - drug effects ; Testis - metabolism ; Testosterone - blood ; Thyroxine - blood ; Training</subject><ispartof>The Journal of steroid biochemistry and molecular biology, 2015-06, Vol.150, p.86-96</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</citedby><cites>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jsbmb.2015.03.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25797375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hengevoss, Jonas</creatorcontrib><creatorcontrib>Piechotta, Marion</creatorcontrib><creatorcontrib>Müller, Dennis</creatorcontrib><creatorcontrib>Hanft, Fabian</creatorcontrib><creatorcontrib>Parr, Maria Kristina</creatorcontrib><creatorcontrib>Schänzer, Wilhelm</creatorcontrib><creatorcontrib>Diel, Patrick</creatorcontrib><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><title>The Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats. Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</description><subject>Amides - pharmacology</subject><subject>Anabolic Agents - pharmacology</subject><subject>Anabolic steroids</subject><subject>Androstenedione - pharmacology</subject><subject>Aniline Compounds - pharmacology</subject><subject>Animals</subject><subject>Estradiol - blood</subject><subject>Estrenes - pharmacology</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Gonadotropin-Releasing Hormone - blood</subject><subject>Humans</subject><subject>Hydrocortisone - blood</subject><subject>Hypothalamic–pituitary–gonadal axis</subject><subject>Hypothalamo-Hypophyseal System - drug effects</subject><subject>Hypothalamo-Hypophyseal System - metabolism</subject><subject>Inhibins - blood</subject><subject>Injections, Subcutaneous</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Luteinizing Hormone - blood</subject><subject>Male</subject><subject>Methandrostenolone - pharmacology</subject><subject>Motor Activity</subject><subject>Muscle Fibers, Skeletal - drug effects</subject><subject>Muscle Fibers, Skeletal - metabolism</subject><subject>Pituitary-Adrenal System - drug effects</subject><subject>Pituitary-Adrenal System - metabolism</subject><subject>Prolactin - blood</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>SARMs</subject><subject>Testis - drug effects</subject><subject>Testis - metabolism</subject><subject>Testosterone - blood</subject><subject>Thyroxine - blood</subject><subject>Training</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kL2O1DAQgC0E4vYWngAJuaRJGNsb2yko0OrgkE6igdpy7MmtV0kcYu-J7XgH3pAnwWEPSqoZab75-wh5xaBmwOTbY31M3djVHFhTg6gBxBOyYVq1FeMcnpINtBIqUBKuyHVKRyiEYOo5ueKNapVQzYakfRy7MKGn2PfocqKxp3byS7zHqSS2i0NwNGVcYvBpLdH5cE7B2YFal8NDyGcaJ5oPSA_nOeaDHewY3K8fP-eQTyHb5Vzy-zhZv7Z8D-kFedbbIeHLx7glXz_cfNnfVnefP37av7-rnGjaXDEhZQ9McVReQSd436HT0qudtLLVmjsELVrtm6Ytp7fAleBNBxYabr22YkveXObOS_x2wpTNGJLDYbATxlMyTGpg7U6rXUHFBXVLTGnB3sxLGMvphoFZbZuj-WPbrLYNCLO63JLXjwtO3Yj-X89fvQV4dwGwvPkQcDHJBZwc-rAU2cbH8N8FvwG_9JVP</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Hengevoss, Jonas</creator><creator>Piechotta, Marion</creator><creator>Müller, Dennis</creator><creator>Hanft, Fabian</creator><creator>Parr, Maria Kristina</creator><creator>Schänzer, Wilhelm</creator><creator>Diel, Patrick</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><author>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Amides - pharmacology</topic><topic>Anabolic Agents - pharmacology</topic><topic>Anabolic steroids</topic><topic>Androstenedione - pharmacology</topic><topic>Aniline Compounds - pharmacology</topic><topic>Animals</topic><topic>Estradiol - blood</topic><topic>Estrenes - pharmacology</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Gonadotropin-Releasing Hormone - blood</topic><topic>Humans</topic><topic>Hydrocortisone - blood</topic><topic>Hypothalamic–pituitary–gonadal axis</topic><topic>Hypothalamo-Hypophyseal System - drug effects</topic><topic>Hypothalamo-Hypophyseal System - metabolism</topic><topic>Inhibins - blood</topic><topic>Injections, Subcutaneous</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Luteinizing Hormone - blood</topic><topic>Male</topic><topic>Methandrostenolone - pharmacology</topic><topic>Motor Activity</topic><topic>Muscle Fibers, Skeletal - drug effects</topic><topic>Muscle Fibers, Skeletal - metabolism</topic><topic>Pituitary-Adrenal System - drug effects</topic><topic>Pituitary-Adrenal System - metabolism</topic><topic>Prolactin - blood</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>SARMs</topic><topic>Testis - drug effects</topic><topic>Testis - metabolism</topic><topic>Testosterone - blood</topic><topic>Thyroxine - blood</topic><topic>Training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hengevoss, Jonas</creatorcontrib><creatorcontrib>Piechotta, Marion</creatorcontrib><creatorcontrib>Müller, Dennis</creatorcontrib><creatorcontrib>Hanft, Fabian</creatorcontrib><creatorcontrib>Parr, Maria Kristina</creatorcontrib><creatorcontrib>Schänzer, Wilhelm</creatorcontrib><creatorcontrib>Diel, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hengevoss, Jonas</au><au>Piechotta, Marion</au><au>Müller, Dennis</au><au>Hanft, Fabian</au><au>Parr, Maria Kristina</au><au>Schänzer, Wilhelm</au><au>Diel, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</atitle><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>2015-06</date><risdate>2015</risdate><volume>150</volume><spage>86</spage><epage>96</epage><pages>86-96</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats. Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25797375</pmid><doi>10.1016/j.jsbmb.2015.03.003</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-0760
ispartof The Journal of steroid biochemistry and molecular biology, 2015-06, Vol.150, p.86-96
issn 0960-0760
1879-1220
language eng
recordid cdi_proquest_miscellaneous_1680194874
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amides - pharmacology
Anabolic Agents - pharmacology
Anabolic steroids
Androstenedione - pharmacology
Aniline Compounds - pharmacology
Animals
Estradiol - blood
Estrenes - pharmacology
Follicle Stimulating Hormone - blood
Gonadotropin-Releasing Hormone - blood
Humans
Hydrocortisone - blood
Hypothalamic–pituitary–gonadal axis
Hypothalamo-Hypophyseal System - drug effects
Hypothalamo-Hypophyseal System - metabolism
Inhibins - blood
Injections, Subcutaneous
Insulin-Like Growth Factor I - metabolism
Luteinizing Hormone - blood
Male
Methandrostenolone - pharmacology
Motor Activity
Muscle Fibers, Skeletal - drug effects
Muscle Fibers, Skeletal - metabolism
Pituitary-Adrenal System - drug effects
Pituitary-Adrenal System - metabolism
Prolactin - blood
Rats
Rats, Wistar
SARMs
Testis - drug effects
Testis - metabolism
Testosterone - blood
Thyroxine - blood
Training
title Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A53%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20effects%20of%20androgen%20anabolic%20steroids%20and%20physical%20activity%20on%20the%20hypothalamic%E2%80%93pituitary%E2%80%93gonadal%20axis&rft.jtitle=The%20Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Hengevoss,%20Jonas&rft.date=2015-06&rft.volume=150&rft.spage=86&rft.epage=96&rft.pages=86-96&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/j.jsbmb.2015.03.003&rft_dat=%3Cproquest_cross%3E1680194874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680194874&rft_id=info:pmid/25797375&rft_els_id=S0960076015000886&rfr_iscdi=true